Company intelligence / Profile preview

MedicInvent

Helsingborg, Sweden

Ownership: Private
Development stage: Other

Overview

MedicInvent AB was a Swedish medical technology company primarily known for developing the InvenJet, a needle-free jet injection system designed for the delivery of vaccines, insulin, and other liquid pharmaceuticals. Founded in 1998 and based in the Lund/Helsingborg life science cluster, the company focused on improving patient compliance and safety by eliminating needle-stick injuries and phobia. The InvenJet technology utilized high-pressure liquid streams to penetrate the skin, offering a potential alternative to traditional syringe-based delivery for biologics. Despite its innovative drug delivery platform, the company faced financial difficulties and its bankruptcy was concluded in 2013.

Therapeutic areas: EndocrinologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on MedicInvent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedicInvent.

Explore the full profile